Microsoft, Adaptive team up for open-access COVID-19 immune response database

Microsoft and Seattle-based Adaptive Biotechnologies launched an open-access database housing data on patients’ immune responses to the novel coronavirus, according to a June 11 news release.

Advertisement

Researchers hope the database, named ImmuneCODE, will help the medical community better understand how T-cells respond to SARS-CoV-2, the virus that causes COVID-19. This availability of immunity data can lead scientists to find the most effective T-cell reaction and use the information to improve COVID-19 diagnostics and treatments.

The database consists of de-identified data from thousands of COVID-19 patients who are ethnically and geographically diverse. 

More articles on data analytics:
HHS updates COVID-19 lab test data reporting requirements: 6 details
Apple updates sharing options on COVID-19 app
New York’s Mount Sinai gets Microsoft grant for COVID-19 data center: 4 details

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.